Skip to content
CapRadio

CapRadio

signal status listen live donate
listen live donate signal status
listen live donate signal status
  • News
    • topics
    • State Government
    • Environment
    • Health Care
    • Race and Equity
    • Business
    • Arts and Lifestyle
    • Food and Sustainability
    • PolitiFact California
  • Music
    • genres
    • Classical
    • Jazz
    • Eclectic
    • Daily Playlist
  • Programs + Podcasts
    • news
    • Morning Edition
    • All Things Considered
    • Marketplace
    • Insight With Vicki Gonzalez
    • music
    • Acid Jazz
    • At the Opera
    • Classical Music
    • Connections
    • Excellence in Jazz
    • Hey, Listen!
    • K-ZAP on CapRadio
    • Mick Martin's Blues Party
    • Programs A-Z
    • Podcast Directory
  • Schedules
    • News
    • Music
    • ClassicalStream
    • JazzStream
    • Weekly Schedule
    • Daily Playlist
  • Community
    • Events Calendar
    • CapRadio Garden
    • CapRadio Reads
    • Ticket Giveaways
  • Support
    • Evergreen Gift
    • One-Time Gift
    • Corporate Support
    • Vehicle Donation
    • Stock Gift
    • Legacy Gift
    • Endowment Gift
    • Benefits
    • Member FAQ
    • e‑Newsletter
    • Drawing Winners
    • Thank You Gifts
  • About Us
  • Contact Us
  • Close Menu
 We Get Support From:
Become a Supporter 
 We Get Support From:
Become a Supporter 

FDA Approves First Rapid COVID-19 Test

By Vanessa Romo | NPR
Saturday, March 21, 2020

The Food and Drug Administration has approved the first rapid point-of-care COVID-19 test, that can deliver results in less than an hour.

Cepheid, a Silicon Valley diagnostics company, made the announcement on Saturday, saying it has received emergency authorization from the government to use the test.

While the agency has approved about a dozen other COVID-19 tests in response to the public health emergency caused by the coronavirus pandemic, this is the first one that can be used at the point of care.

Cepheid said the test kits will be available by the end of the month.

Until now, to get test result, a health care worker would take a swab from the back of a person's nose, and send it off to a public health, commercial or hospital lab, or to a lab at the Centers for Disease Control and Prevention in Atlanta. The process can take days.

The newly approved test kit still involves taking a nasal swab, but the test can be done in a doctor's office or clinic with a detection time of approximately 45 minutes, according to Cepheid.

"During this time of increased demand for hospital services, Clinicians urgently need an on-demand diagnostic test for real-time management of patients being evaluated for admission to health-care facilities," said Dr. David Persing, chief medical and technology officer at Cepheid.

He added: "An accurate test delivered close to the patient can be transformative — and help alleviate the pressure that the emergence of the 2019-nCoV outbreak has put on healthcare facilities that need to properly allocate their respiratory isolation resources."

State and local government leaders have been putting pressure on the Trump administration and the coronavirus task force led by Vice President Mike Pence to address widespread testing shortages. In response, the administration has turned to the private sector to help develop tests, vaccines and therapeutic medicines to help stem the pandemic.

On Saturday, Pence confirmed more than 195,000 people have been tested for the respiratory virus, not including those who were tested in county hospitals or health care labs around the nation. Of those, roughly 19,350 have tested positive for the coronavirus.

Copyright 2022 NPR. To see more, visit https://www.npr.org.

View this story on npr.org
Follow us for more stories like this

CapRadio provides a trusted source of news because of you.  As a nonprofit organization, donations from people like you sustain the journalism that allows us to discover stories that are important to our audience. If you believe in what we do and support our mission, please donate today.

Donate Today  

Sign up for ReCap and never miss the top stories

Delivered to your inbox every Friday.

 

Check out a sample ReCap newsletter.

Thanks for subscribing!

Thank you for signing up for the ReCap newsletter! We'll send you an email each Friday with the top stories from CapRadio.

Browse all newsletters

Most Viewed

Abortion is still legal in California. Here are answers to questions about access in the state.

California coronavirus updates: COVID-19 cases are increasing globally

Northern California wildfires: Where to find updates on air quality, evacuations, and official information

Still testing positive after day 10? How to decide when to end your COVID isolation

With California budget surplus projected at $97 billion, Newsom proposes driver rebates, more reproductive health funding

We Get Support From:
Become a Supporter

Back to Top

  • CapRadio

    7055 Folsom Boulevard
    Sacramento, CA 95826-2625

    • (916) 278-8900
    • Toll-free (877) 480-5900
    • Email Us
    • Submit a News Tip
  • Contact Us

  • About Us

    • Contact Us / Feedback
    • Coverage
    • Directions
    • Careers & Internships
    • Mission / Vision / Core Values
    • Press
    • Staff Directory
    • Board of Directors
  • Listening Options

    • Mobile App
    • On Air Schedules
    • Smart Speakers
    • Playlist
    • Podcasts
    • RSS
  • Connect With Us

    •  Facebook
    •  Twitter
    •  Instagram
    •  YouTube
  • Donate

  • Listen

  • Newsletters

CapRadio stations are licensed to California State University, Sacramento. © 2022, Capital Public Radio. All Rights Reserved. Privacy Policy | Website Feedback FCC Public Files: KXJZ KKTO KUOP KQNC KXPR KXSR KXJS. For assistance accessing our public files, please call 916-278-8900 or email us.